Singapore

Multi-Agent Path Finding (MAPF) is a fundamental problem in robotics and logistics, where multiple agents must reach their goals without collisions. While deep Multi-Agent Reinforcement Learning methods have recently shown impressive scalability and adaptability, their black-box nature hinders interpretability and trust—crucial aspects for deployment in real-world systems. In this work, we propose an interpretable policy distillation framework for MAPF. We first formulate MAPF as a stochastic game and execute a trained neural policy across diverse environments to build a large dataset of state–action pairs. We then distill this neural policy into a decision tree model that captures its underlying decision rules while maintaining strong performance. Through extensive evaluation, we analyze the trade-off between interpretability and performance, demonstrating that our distilled models achieve high fidelity to the original policy while providing transparent, human-understandable reasoning about agent behavior.

AAAI 2026

Interpretable Multi-Agent Path Finding via Decision Tree Extraction from Neural Policies

AAMAS is the leading scientific conference for research in autonomous agents and multi-agent systems. The AAMAS conference series was initiated in 2002 as the merging of three respected scientific meetings: the International Conference on Multi-Agent Systems (ICMAS), the International Workshop on Agent Theories, Architectures, and Languages (ATAL), and the International Conference on Autonomous Agents (AA). The aim of the joint conference is to provide a single, high-profile, internationally-respected archival forum for scientific research in the theory and practice of autonomous agents and multi-agent systems.

Browse keynotes, discussions, panels and over 300 presentations.


AAMAS 2020

AAMAS is the leading scientific conference for research in autonomous agents and multi-agent systems. The AAMAS conference series was initiated in 2002 as the merging of three respected scientific meetings: the International Conference on Multi-Agent Systems (ICMAS), the International Workshop on Agent Theories, Architectures, and Languages (ATAL), and the International Conference on Autonomous Agents (AA). 

workshop paper

We are pleased to announce the Fortieth AAAI Conference on Artificial Intelligence (AAAI-26), which will be held in Singapore EXPO from January 20 to January 27, 2026.

The purpose of the AAAI conference series is to promote research in Artificial Intelligence (AI) and foster scientific exchange between researchers, practitioners, scientists, students, and engineers across the entirety of AI and its affiliated disciplines. AAAI-26 will feature technical paper presentations, special tracks, invited speakers, workshops, tutorials, poster sessions, senior member presentations, competitions, and exhibit programs, and a range of other activities to be announced.<br><br>

To access this event page, you need to log in with the **email address you registered with**. <br>Access credentials will be sent to your email from Underline -  subject line "Welcome to AAAI 2026". Please be sure to check your spam email folder if you do not see an email confirmation right away.

Please log in

To access this event page, you are required to register.
Please complete your registration to continue.

We recommend reading [**the registration information**](https://aaai.org/conference/aaai/aaai-26/registration/) first.

**Online Registration Form**: https://aaai.getregistered.net/conference-2026 

Registration Required

We are pleased to announce the Fortieth AAAI Conference on Artificial Intelligence (AAAI-26), which will be held in Singapore EXPO from January 20 to January 27, 2026.

Multi-Agent Path Finding (MAPF) is a representative multi-agent coordination problem, where multiple agents are required to navigate to their respective goals without collisions. Solving MAPF optimally is known to be NP-hard, leading to the adoption of learning-based approaches to alleviate the online computational burden. Prevailing approaches, such as Graph Neural Networks (GNNs), are typically constrained to *pairwise* message passing between agents. However, this limitation leads to suboptimal behaviours and critical issues, such as attention dilution, particularly in dense environments where group (i.e. beyond just two agents) coordination is most critical. Despite the importance of such higher-order interactions, existing approaches have not been able to fully explore them. To address this representational bottleneck, we introduce HMAGAT (Hypergraph Multi-Agent Attention Network), a novel architecture that leverages attentional mechanisms over directed hypergraphs to explicitly capture group dynamics. Empirically, HMAGAT establishes a new state-of-the-art among learning-based MAPF solvers: e.g., despite having just 1M parameters and being trained on 100$\times$ less data, it outperforms the current SoTA 85M parameter model. Through detailed analysis of HMAGAT's attention values, we demonstrate how hypergraph representations mitigate the attention dilution inherent in GNNs and capture complex interactions where pairwise methods fail. Our results illustrate that appropriate inductive biases are often more critical than the training data size or sheer parameter count for multi-agent problems.

Pairwise is Not Enough: Hypergraph Neural Networks for Multi-Agent Pathfinding

Federated learning (FL) enables clients to collaboratively train a shared model in a distributed manner, setting it apart from traditional deep learning paradigms. However, most existing FL research assumes consistent client participation, overlooking the practical scenario of dynamic participation (DPFL), where clients may intermittently join or leave during training. Moreover, no existing benchmarking framework systematically supports the study of DPFL-specific challenges. In this work, we present the first open-source framework explicitly designed for benchmarking FL models under dynamic client participation. Our framework provides configurable data distributions, participation patterns, and evaluation metrics tailored to DPFL scenarios. Using this platform, we benchmark four major categories of widely adopted FL models and uncover substantial performance degradation under dynamic participation. To address these challenges, we further propose Knowledge-Pool Federated Learning (KPFL), a generic plugin that maintains a shared knowledge pool across both active and idle clients. KPFL leverages dual-age and data-bias weighting, combined with generative knowledge distillation, to mitigate instability and prevent knowledge loss. Extensive experiments demonstrate the significant impact of dynamic participation on FL performance and the effectiveness of KPFL in improving model robustness and generalization.

Dynamic Participation in Federated Learning: Benchmarks and a Knowledge Pool Plugin

The orbital environment is increasingly congested, heightening collision risk and demanding robust Space Situational Awareness (SSA). Ground-based tracking and centralized learning face latency, fragmented datasets, and strict privacy limits on telemetry sharing. While ML aids orbital prediction, purely data-driven models fail under sparse or irregular observations; Physics-Informed Neural Networks (PINNs) embed dynamics for physical consistency. However, locally trained PINNs lack shared context, fragmenting awareness. Collaboration is often constrained by privacy policy, export controls, or mission secrecy—sometimes forcing purely local learning and leaving blind spots. This motivates Federated Learning (FL), where satellites share model updates (not raw data) to refine physics-consistent predictors while preserving data autonomy. However, single-server FL is ill-suited for orbital networks, as it creates a single point of failure, over-smooths data, and exposes vulnerability to link outages. We therefore propose Graph-Decentralized Federated Learning (Graph-DFL) for multi-satellite SSA: a serverless framework where satellites exchange quantized incremental updates only with neighbors and reach consensus via topology-aware diffusion. Each Low Earth Orbit (LEO) client trains a GRU-based deinterleaver and a local PINN, while Medium Earth Orbit (MEO) relays apply confidence-weighted Cayley–Menger × Light-Cone (CM × LC) fusion. Experiments on real Two-Line Element (TLE)–derived SGP4 trajectories show that Graph-DFL achieves high deinterleaver accuracy and low trajectory RMSE, indicating a resilient, physics-consistent, privacy-preserving solution for SSA without centralization.

Learning in Orbit: A Physics-Aware Graph-Decentralized Federated Learning for Multi-Satellite Space Situational Awareness

Fragment-based drug discovery (FBDD) leverages small molecular fragments as starting points for drug develop- ment. While SMILES is widely used in cheminformat- ics, its syntax introduces parsing challenges that can af- fect model performance. DeepSMILES, a postfix variant of SMILES, addresses these issues by eliminating paired ring closures and balanced parentheses. In this work, we intro- duce DeepBERTa, a ChemBERTa-based architecture trained on DeepSMILES, and apply it in a downstream FBDD task using a dataset of approximately 34,000 molecule–fragment pairs derived from FDA-approved drugs, with fragments se- lected by docking against the mTOR kinase. We ran both SMILES and DeepSMILES-based models in parallel and show that 1 a hybrid approach, which selects the best predic- tion from either model, raises the mean Tanimoto similarity from 0.290 (SMILES) to 0.347, with DeepSMILES providing the better prediction in 13% of the cases.

A Hybrid SMILES-DeepSMILES Transformer Approach Improving Fragment Prediction in Fragment-Based Drug Discovery with DeepBERTa

Protein flexibility and induced-fit effects are critical but often overlooked aspects of structure-based drug design. Most existing generative models treat proteins as rigid scaffolds, limiting their ability to predict realistic binding geometries. We present Co-Diffuse, a novel framework that jointly generates ligand molecules and their corresponding protein binding pocket conformations using SE(3)-equivariant diffusion models. By explicitly modeling the mutual adaptation between proteins and ligands, Co-Diffuse captures the dynamic nature of molecular recognition. Comprehensive evaluations on PDBbind, CrossDocked2020, and cryptic site benchmarks demonstrate that Co-Diffuse achieves an average RMSD improvement of 1.8 Å over leading docking baselines and yields more accurate binding affinity predictions. Ablation studies highlight the importance of joint generation and physics-informed constraints. Co-Diffuse represents a significant step toward dynamic, physically grounded generative modeling for structure-based drug design.



Co-Diffuse: Generative Co-Design of Protein–Ligand Interactions via 3D Equivariant Diffusion Models with Induced-Fit Awareness

SynergyIF: Multimodal Intermediate Fusion for Deep Tensor Completion in Anticancer Drug Synergy Prediction

Parkinson’s disease (PD) drug discovery is uncertainty- and constraint-laden: candidates must match disease mechanisms (e.g., GBA1, 
-synuclein), cross the BBB, and meet developability/novelty requirements amid fragmented evidence. We present PD Brain, a disease-specialized, continuously operating platform that turns natural-language intents into executable end-to-end workflows. PD Brain is built on a PD Deep Knowledge Base (DKB) comprising: (i) an Evidence KG of PD facts, (ii) an Understanding Graph that contracts facts into mechanism motifs (Drug
Target
Pathway
Cell-type/Region
Phenotype), and (iii) a Reasoning Graph that scores causal paths under CNS predicates (BBB transport, SNc expression, exposure thresholds) with calibrated uncertainty. The system \emph{plans, auto-codes, executes, and self-updates} the pipeline.

In a GBA1-focused study, PD Brain expanded an Ambroxol seed to 
1,100 analogs, used a multi-agent MoA debate to triage to 
500, applied variant-aware docking (GCase WT and PD-linked mutants) and BBB-aware ADMET to 64, and shortlisted 5 novel leads. A representative candidate Cpd-1 (SMILES: C1C(=O)CCC(CC1NCC2=C(C(=CC(=C2)Br)Br)N)O) docked to GCase at 
kcal/mol with predicted brain penetration, 
90% human intestinal absorption, 
7.7 h plasma half-life, and moderate toxicity risk; other shortlist molecules exceeded it on specific criteria.

Key contributions: a PD-vertical planner (Plan), automatic tool selection and code synthesis (Design), a provenance-first OS for robust execution (Execute), and continuous DKB-driven updates with drift/contradiction handling (Evolve). We discuss implications for disease-focused automated discovery, including oversight, IP awareness, and continual learning.

Parkinson’s on Purpose: A Disease-Vertical Agentic Pipeline from Literature to Leads

Accurate prediction of patient-specific drug responses to new therapeutic compounds is essential for advancing personalized drug discovery and development. However, limited patient-derived datasets and biological heterogeneity between preclinical and clinical data constrain predictive models generalizability. Existing methods that utilize cell-line drug screens to infer patient outcomes often struggle with distributional shifts and lack biological context.

Here, we have presented DCODE (Domain-aligned Context-aware multimODal attEntion autoencoder), a novel framework that learns domain-consistent molecular representations by aligning latent spaces between preclinical and clinical data. This alignment mitigates distributional shifts while preserving clinically relevant biological signals. A gene–drug interaction attention module further models nonlinear treatment dependencies, allowing DCODE to disentangle the molecular determinants of drug response.

Extensive comparative analyses demonstrated that DCODE outperformed state-of-the-art models, including CODE-AE, in predictive accuracy and robustness. When evaluated on independent clinical datasets covering five drugs for 90808 patients, DCODE achieved over 70% accuracy in predicting responses to cisplatin, sorafenib, and temozolomide. Our results are consistent with existing clinical observations, highlighting its potential for developing personalized therapy and drug response biomarkers.

A domain-aligned multimodal attention autoencoder for predicting personalized clinical drug response from cell-line drug screens

The utility of large language models (LLMs) for reviewing clinical trial protocols—focusing on statistical analysis plans (SAPs) and pharmacokinetics–pharmacodynamics (PK–PD)—was evaluated using a testbed of 15 trials spanning small molecules, biologics, and global public-health studies. GPT-4o, prompted with a regulatory-expert persona, was tasked to extract study-design attributes, surface relevant regulatory guidance, and produce structured SAP and PK–PD evaluations. Outputs were benchmarked against source protocols/registries and graded post hoc by ChatGPT and Grok using a predefined rubric. Disease, interventions/comparators, and trial sample size were correctly identified for 15/15, 15/15, and 14/15 trials, respectively; overall protocol-based correctness was 95% (80% versus ClinicalTrials.gov actuals reflecting realized enrollments). Frequently surfaced guidance included ICH/FDA E9 for SAPs and FDA Population Pharmacokinetics for PK–PD. SAP summaries were generally coherent, with occasional context errors (e.g., outdated endpoint adjudication, sidedness of tests, incomplete multiplicity handling). PK–PD objectives/measures were correctly captured in 8/9 protocols and analysis methods in 7/8, including dose-proportionality reasoning for a Phase I example. Cross-model grading showed similar judgments on primary-outcome accuracy, statistical-method correctness, and E9 alignment, with divergence in clinical-interpretability scores. Findings support an LLM-assisted, human-in-the-loop workflow to triage and standardize protocol reviews at scale, while highlighting needs for version awareness, explicit multiplicity control, and more precise guidance retrieval in complex or adaptive designs.

Large Language Models for Clinical Trial Protocol Assessments

The Ribonucleic Acid (RNA) inverse folding problem, designing nucleotide sequences that fold into specific tertiary structures, is a fundamental computational biology problem with important applications in synthetic biology and bioengineering. The design of complex three-dimensional RNA architectures remains computationally demanding and mostly unresolved, as most existing approaches focus on secondary structures. In order to address tertiary RNA inverse folding, we present BeeRNA, a bio-inspired method that employs the Artificial Bee Colony (ABC) optimization algorithm. Our approach combines base-pair distance filtering with RMSD-based structural assessment using RhoFold for structure prediction, resulting in a two-stage fitness evaluation strategy. To guarantee biologically plausible sequences with balanced GC content, the algorithm takes thermodynamic constraints and adaptive mutation rates into consideration. In this work, we focus primarily on short and medium-length RNAs (
100 nucleotides), a biologically significant regime that includes microRNAs (miRNAs), aptamers, and ribozymes, where BeeRNA achieves high structural fidelity with practical CPU runtimes. The lightweight, training-free implementation will be publicly released for reproducibility, offering a promising bio-inspired approach for RNA design in therapeutics and biotechnology.

Downloads

Next from AAAI 2026

Pairwise is Not Enough: Hypergraph Neural Networks for Multi-Agent Pathfinding

Similar lecture

Lifelong Multi-Agent Path Finding in Large-Scale Warehouses

Stay up to date with the latest Underline news!

PRESENTATIONS

CONFERENCES

COMPANY

RESOURCES

.css-70qvj9{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;}Downloads

Next from AAAI 2026

Pairwise is Not Enough: Hypergraph Neural Networks for Multi-Agent Pathfinding

Similar lecture

Lifelong Multi-Agent Path Finding in Large-Scale Warehouses

Stay up to date with the latest Underline news!

PRESENTATIONS

CONFERENCES

COMPANY

RESOURCES

Downloads